These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3527369)

  • 1. [Human vaccination against brucellosis (Charles Nicolle)].
    Roux J
    Bull Acad Natl Med; 1986 Feb; 170(2):289-92. PubMed ID: 3527369
    [No Abstract]   [Full Text] [Related]  

  • 2. A history of the development of Brucella vaccines.
    Avila-Calderón ED; Lopez-Merino A; Sriranganathan N; Boyle SM; Contreras-Rodríguez A
    Biomed Res Int; 2013; 2013():743509. PubMed ID: 23862154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination against human brucellosis. 2 years of experience].
    Bentejac MC; Biron G; Bertrand A; Bascoul S
    Dev Biol Stand; 1984; 56():531-5. PubMed ID: 6436111
    [No Abstract]   [Full Text] [Related]  

  • 4. Live bacterial vaccines for animals.
    Desmettre P
    Dev Biol Stand; 1995; 84():221-5. PubMed ID: 7796957
    [No Abstract]   [Full Text] [Related]  

  • 5. Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.
    Martins Rda C; Irache JM; Gamazo C
    Expert Rev Vaccines; 2012 Jan; 11(1):87-95. PubMed ID: 22149711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovine brucellosis: repeated vaccination with Rev 1 vaccine and the prevalence of the disease in the Winburg district.
    Erasmus JA; Bergh EC
    J S Afr Vet Assoc; 1985 Dec; 56(4):205-8. PubMed ID: 3836306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a Brucella vaccine for humans.
    Perkins SD; Smither SJ; Atkins HS
    FEMS Microbiol Rev; 2010 May; 34(3):379-94. PubMed ID: 20180858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination strategies for managing brucellosis in Yellowstone bison.
    Treanor JJ; Johnson JS; Wallen RL; Cilles S; Crowley PH; Cox JJ; Maehr DS; White PJ; Plumb GE
    Vaccine; 2010 Oct; 28 Suppl 5():F64-72. PubMed ID: 20362620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-brucellosis human vaccination with an antigenic fraction of Brucella melitensis].
    Roux J; Serre A; Asselineau J; Lacave C
    Bull Acad Natl Med; 1970; 154(15):318-22. PubMed ID: 4913684
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipopolysaccharide as a target for brucellosis vaccine design.
    Conde-Álvarez R; Arce-Gorvel V; Gil-Ramírez Y; Iriarte M; Grilló MJ; Gorvel JP; Moriyón I
    Microb Pathog; 2013 May; 58():29-34. PubMed ID: 23219811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectivity of Rev 1 vaccine in rams against brucella ovis infection.
    Gradwell DV; Van Zyl FE
    J S Afr Vet Assoc; 1975 Dec; 46(4):349-51. PubMed ID: 1223287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of prevention of human brucellosis in the USSR].
    Verchilova PA
    Bull Off Int Epizoot; 1965; 63(7):1265-77. PubMed ID: 5864694
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vaccination of goats against brucellosis].
    Ivanov MM; Tavamaĭshvili ME
    Veterinariia; 1971 Feb; 2():48-9. PubMed ID: 5166285
    [No Abstract]   [Full Text] [Related]  

  • 18. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

  • 19. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the study of prevention and control of Brucellosis in China in last 50 years].
    Shang D
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):55-7. PubMed ID: 15460005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.